NL-OMON20993暂停不适用
An open, randomised, controlled trial in HIV-1 infected children starting or switching to a new antiretroviral therapy (ART) regimen. Findings to what level therapeutic drug monitoring is needed related to achieve full viral suppression and avoidance of resistence long term.
Paediatric European Network for Treatment of AIDS (PENTA)0 个研究点目标入组 166 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 166
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Confirmed HIV-infected, i.e. positive plasma HIV-1 RNA or DNA test on two consecutive occasions (for children less than 18 months old), or positive HIV serology (for children aged 18 months and older) aged one month to 17 years inclusive;
- •2. Parents/guardians, and children where appropriate, are willing and able to give informed consent;
排除标准
- •Grade 3 or 4 creatinine or liver function tests.
研究者
相似试验
暂停
不适用
HAART followed by maintenance with monotherapy-Kaletra (MAIMOKA).HIV/AIDSNL-OMON20599VU Medical CenterandUniversity Medical Center Utrecht240
已完成
1 期
A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected AdultsHIV InfectionsNCT04224701International AIDS Vaccine Initiative48
Unknown
2 期
Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected PatientsHIV-1-infectionNCT03536234Immune System Regulation AB52
已完成
2 期
TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 TrialHIV InfectionNCT00111280Tibotec Pharmaceuticals, Ireland48
已完成
1 期
Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United StatesHIV InfectionsNCT03382418National Institute of Allergy and Infectious Diseases (NIAID)45